Boston Scientific is a Buy with a $109 target and 14% upside from strong demand, Q3 beats, raised FY25 guidance, and growth ...
Discover top GASV stocks for 2024-2026 with up to 50.81% gains and high yields. Learn which value picks offer stable ...
Revenue climbed 33.7% year over year to US$25.8 million Gross profit soared 79.5% year over year to US$4.3 million, with improved margins Total assets nearly tripled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback